Frazier Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.7K Hold
63
0.01% 332
2025
Q4
$19.1K Hold
63
0.01% 282
2025
Q3
$21.5K Hold
63
0.01% 264
2025
Q2
$15.3K Buy
63
+15
+31% +$3.68K 0.01% 296
2025
Q1
$13.1K Hold
48
0.01% 295
2024
Q4
$8.82K Hold
48
0.01% 364
2024
Q3
$10.8K Sell
48
-22
-31% -$3.96K 0.01% 355
2024
Q2
$9.99K Hold
70
0.01% 436
2024
Q1
$10.9K Buy
70
+22
+46% +$3.54K 0.01% 391
2023
Q4
$8.66K Buy
+48
New +$8.68K 0.01% 382

Other funds holding ONC

Frazier Financial Advisors's ONC Position: Q1 2026 in Review

Frazier Financial Advisors held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 63 shares worth $18.7K. The position accounts for 0.01% of the portfolio, ranked #332.

Frazier Financial Advisors first reported a position in ONC in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.5K in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Frazier Financial Advisors held 63 shares of BeOne Medicines Ltd worth $18.7K as of Q1 2026.
  • Frazier Financial Advisors left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up 0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #332 holding.
  • Frazier Financial Advisors first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's BeOne Medicines Ltd position peaked at $21.5K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.